News

Vancouver, June 5th 2007 - Xemplar Energy Corp. (TSXV: XE) ("Xemplar" or the "Company") is pleased to announce the appointment of Dr. Hikmet Akin, (Ph.D. Eng, P.Geo) to the board of directors.

Dr. Akin has over 35 years of experience in exploration, mining development and project evaluation mostly related to Uranium. Dr. Akin was the CEO and President of the original Uranerz Group of companies before its sale in 1998 to Cameco Corporation. Uranerz, as one of the major Uranium producers in the world, successfully pursued mining and exploration activities in various countries and different continents. In 1985, he became a professor at the Technical University of Berlin and in 1988 published a book on geostatistics and reserve estimations. Since 1978, he has held various managerial and staff positions within Uranerz with increasing responsibilities at the professional and executive level. After the sale of Uranerz in 1998, Dr. Akin worked as an international consultant to various mining entities. Dr. Akin is currently the President and CEO of RPT Uranium Corp (TSX-V: RPT). Dr Akin is also a member of Forsys Metals Corp (TSX: FSY) advisory board which he joined in April 2006.

Dr. Akin and his former Uranerz Group evaluated numerous uranium occurrences in many locations throughout the world. His wealth of knowledge and his contacts in the uranium industry will significantly enhance Xemplar's corporate strategy in the uranium exploration sector.

Gennen McDowall, President and CEO of the Company said, "We are very pleased that Hikmet has agreed to join the Xemplar board. This is a further strategic board appointment as his operational skills and knowledge of in-situ recovery techniques will complement our high-quality team, and I know that we will be able to draw on Hikmet's vast experience and impressive track record at the former Uranerz Group of companies. He arrives at a most exciting time for Xemplar as we are currently evaluating our various uranium projects in Namibia."

Dr Akin recently completed a field visit to Xemplar's uranium projects in Namibia. His comments regarding the potential use of in-situ recovery techniques for the Engo Valley "roll-front" uranium deposit were extremely pertinent and will be acted upon.

The Company has granted Dr. Hikmet incentive stock options to purchase up to a total of 250,000 common shares in the capital stock of the company, exercisable for a period of five years, at a price of $1.80 per share.

THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION. "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: THIS NEWS RELEASE CONTAINS FORWARD LOOKING STATEMENTS THAT ARE NOT HISTORICAL FACTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE SET FORTH IN OR IMPLIED HEREIN.

News Releases

Dr. Hikmet Akin Appointed to Xemplar Board